Research in CLL is ongoing, with new treatments and therapies being developed to improve patient outcomes. Recent advances include the development of CAR-T cell therapy, which uses genetically modified T cells to target cancer cells, and novel targeted therapies that inhibit specific proteins involved in the growth of CLL cells. Clinical trials are continuously exploring new drug combinations and treatment approaches.
